Paper39768461
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis.
Perrotta FM and 2 others. J Clin Med, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis. Papers, record 39768461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39768461
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| not applicable | Ricerca Corrente" funding scheme of the Ministry of Health | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4037555 | Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. | Ann Intern Med | 1985 | https://conductscience.org/library/papers/4037555 | PubMed |
| 2 | 3883172 | Efficacy of low-dose methotrexate in rheumatoid arthritis. | N Engl J Med | 1985 | https://conductscience.org/library/papers/3883172 | PubMed |
| 3 | 19740904 | Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis. | Ann Rheum Dis | 2010 | https://conductscience.org/library/papers/19740904 | PubMed |
| 4 | 11838843 | Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study. | J Rheumatol | 2002 | https://conductscience.org/library/papers/11838843 | PubMed |
| 5 | 18064739 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. | Lancet | 2007 | https://conductscience.org/library/papers/18064739 | PubMed |
| 6 | 14677172 | Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis. | J Rheumatol | 2003 | https://conductscience.org/library/papers/14677172 | PubMed |
| 7 | 35761070 | Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/35761070 | PubMed |
| 8 | 8235288 | Long-term experience with low dose methotrexate in rheumatoid arthritis. | Rheumatol Int | 1993 | https://conductscience.org/library/papers/8235288 | PubMed |
| 9 | 16871531 | Classification criteria for psoriatic arthritis: development of new criteria from a large international study. | Arthritis Rheum | 2006 | https://conductscience.org/library/papers/16871531 | PubMed |
| 10 | 19633799 | [Long-term survival of methotrexate in psoriatic arthritis]. | Reumatismo | 2009 | https://conductscience.org/library/papers/19633799 | PubMed |
| 11 | 36933068 | Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study. | Rheumatol Int | 2023 | https://conductscience.org/library/papers/36933068 | PubMed |
| 12 | 31474599 | Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. | J Rheumatol | 2020 | https://conductscience.org/library/papers/31474599 | PubMed |
| 13 | 30747501 | Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial. | Arthritis Rheumatol | 2019 | https://conductscience.org/library/papers/30747501 | PubMed |
| 14 | 15208176 | Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/15208176 | PubMed |
| 15 | 6394758 | A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. | J Rheumatol | 1984 | https://conductscience.org/library/papers/6394758 | PubMed |
| 16 | 22344575 | A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. | Rheumatology (Oxford) | 2012 | https://conductscience.org/library/papers/22344575 | PubMed |
| 17 | 26470835 | An overview of low disease activity and remission in psoriatic arthritis. | Clin Exp Rheumatol | 2015 | https://conductscience.org/library/papers/26470835 | PubMed |
| 18 | 23221588 | ACR/EULAR 2010 rheumatoid arthritis classification criteria. | Rheumatology (Oxford) | 2012 | https://conductscience.org/library/papers/23221588 | PubMed |
| 19 | 11454634 | Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. | Ann Rheum Dis | 2001 | https://conductscience.org/library/papers/11454634 | PubMed |
| 20 | 8646436 | Effect of age on the efficacy and tolerance of methotrexate in rheumatoid arthritis. | Br J Rheumatol | 1996 | https://conductscience.org/library/papers/8646436 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42307638 | Pharmacological assessment of drugs retained in the 1st and 24th WHO Essential Medicines List (1977-2025). | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42307638 | PubMed |
| 41836019 | Clinical characteristics and risk factors of severe myelosuppression in rheumatoid arthritis patients with csDMARD non-adherence: a case series. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41836019 | PubMed |
| 41658163 | ROS-Scavenging Bamboo-Derived Carbon Dot-Methotrexate Nanocomposite Ameliorates Rheumatoid Arthritis through Dual Therapeutic Mechanisms. | ACS Omega | 2026 | https://conductscience.org/library/papers/41658163 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39768461
GET https://conductscience.org/api/papers/v1/39768461/references?page=2